tsoledronihappo sun 4 mg / 5 ml infuusiokonsentraatti, liuosta varten
sun pharmaceutical industries b.v - happo zoledronicum monohydricum - infuusiokonsentraatti, liuosta varten - 4 mg / 5 ml - tsoledronihappo
tsoledronihappo hameln 4 mg / 5 ml infuusiokonsentraatti, liuosta varten
hameln pharma gmbh - zoledronic acid monohydrate - infuusiokonsentraatti, liuosta varten - 4 mg / 5 ml - tsoledronihappo
esomeprazol krka 40 mg enterokapseli, kova
krka sverige ab - esomeprazole magnesium dihydrate - enterokapseli, kova - 40 mg - esomepratsoli
esomeprazol ratiopharm 40 mg enterokapseli, kova
ratiopharm gmbh - esomeprazole magnesium dihydrate - enterokapseli, kova - 40 mg - esomepratsoli
esomeprazol actavis 20 mg enterotabletti
actavis group ptc ehf - esomeprazole magnesium dihydrate - enterotabletti - 20 mg - esomepratsoli
esomeprazol actavis 40 mg enterotabletti
actavis group ptc ehf - esomeprazole magnesium dihydrate - enterotabletti - 40 mg - esomepratsoli
somac control
takeda gmbh - pantopratsoli - gastroesofageaalinen refluksi - protonipumpun estäjät - refluksi-oireiden lyhytkestoinen hoito (esim. närästys, hapon regurgitaatio) aikuisilla.
celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - doksorubisiinihydrokloridia - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastiset aineet - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).
exparel liposomal
pacira ireland limited - bupivacaine - acute pain - amides, anesthetics, local - exparel liposomal is indicated:in adults as a brachial plexus block or femoral nerve block for treatment of post-operative pain. in adults and children aged 6 years or older as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds.
arikayce liposomal
insmed netherlands b.v. - amikacin sulfate - hengitystietulehdukset - systeemiset bakteerilääkkeet, - arikayce liposomal is indicated for the treatment of non-tuberculous mycobacterial (ntm) lung infections caused by mycobacterium avium complex (mac) in adults with limited treatment options who do not have cystic fibrosis.